 | • レポートコード：MRC2-11QY11926 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は女性用性的欲求低下障害（HSDD）治療薬のグローバル市場について調査・分析したレポートです。種類別（BP-101、ブレメラノチド、塩酸ゲピロンER、PVT-011、その他）市場規模、用途別（外来患者、入院患者）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別女性用性的欲求低下障害（HSDD）治療薬の競争状況、市場シェア ・世界の女性用性的欲求低下障害（HSDD）治療薬市場：種類別市場規模 2015年-2020年（BP-101、ブレメラノチド、塩酸ゲピロンER、PVT-011、その他） ・世界の女性用性的欲求低下障害（HSDD）治療薬市場：種類別市場規模予測 2021年-2026年（BP-101、ブレメラノチド、塩酸ゲピロンER、PVT-011、その他） ・世界の女性用性的欲求低下障害（HSDD）治療薬市場：用途別市場規模 2015年-2020年（外来患者、入院患者） ・世界の女性用性的欲求低下障害（HSDD）治療薬市場：用途別市場規模予測 2021年-2026年（外来患者、入院患者） ・北米の女性用性的欲求低下障害（HSDD）治療薬市場分析：米国、カナダ ・ヨーロッパの女性用性的欲求低下障害（HSDD）治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの女性用性的欲求低下障害（HSDD）治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の女性用性的欲求低下障害（HSDD）治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの女性用性的欲求低下障害（HSDD）治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Emotional Brain BV、GlaxoSmithKline Plc、Palatin Technologies Inc、Pivot Pharmaceuticals Inc、Strategic Science & Technologies LLC ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Female Hypoactive Sexual Desire Disorder Therapeutics Market
The global Female Hypoactive Sexual Desire Disorder Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Female Hypoactive Sexual Desire Disorder Therapeutics Scope and Market Size
Female Hypoactive Sexual Desire Disorder Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Female Hypoactive Sexual Desire Disorder Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Emotional Brain BV
GlaxoSmithKline Plc
Palatin Technologies Inc
Pivot Pharmaceuticals Inc
Strategic Science & Technologies LLC
…
Market segment by Type, the product can be split into
BP-101
Bremelanotide
Gepirone Hydrochloride ER
PVT-011
Others
Market segment by Application, split into
Out-Patient
In-Patient
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Female Hypoactive Sexual Desire Disorder Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 BP-101
1.4.3 Bremelanotide
1.4.4 Gepirone Hydrochloride ER
1.4.5 PVT-011
1.4.6 Others
1.5 Market by Application
1.5.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Out-Patient
1.5.3 In-Patient
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Perspective (2015-2026)
2.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Growth Trends by Regions
2.2.1 Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Female Hypoactive Sexual Desire Disorder Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Female Hypoactive Sexual Desire Disorder Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Female Hypoactive Sexual Desire Disorder Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Female Hypoactive Sexual Desire Disorder Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Female Hypoactive Sexual Desire Disorder Therapeutics Players by Market Size
3.1.1 Global Top Female Hypoactive Sexual Desire Disorder Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Concentration Ratio
3.2.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Female Hypoactive Sexual Desire Disorder Therapeutics Revenue in 2019
3.3 Female Hypoactive Sexual Desire Disorder Therapeutics Key Players Head office and Area Served
3.4 Key Players Female Hypoactive Sexual Desire Disorder Therapeutics Product Solution and Service
3.5 Date of Enter into Female Hypoactive Sexual Desire Disorder Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2015-2020)
5.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (2015-2020)
6.2 Female Hypoactive Sexual Desire Disorder Therapeutics Key Players in North America (2019-2020)
6.3 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2015-2020)
6.4 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (2015-2020)
7.2 Female Hypoactive Sexual Desire Disorder Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2015-2020)
7.4 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (2015-2020)
8.2 Female Hypoactive Sexual Desire Disorder Therapeutics Key Players in China (2019-2020)
8.3 China Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2015-2020)
8.4 China Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (2015-2020)
9.2 Female Hypoactive Sexual Desire Disorder Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2015-2020)
9.4 Japan Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (2015-2020)
10.2 Female Hypoactive Sexual Desire Disorder Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (2015-2020)
11.2 Female Hypoactive Sexual Desire Disorder Therapeutics Key Players in India (2019-2020)
11.3 India Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2015-2020)
11.4 India Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (2015-2020)
12.2 Female Hypoactive Sexual Desire Disorder Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Emotional Brain BV
13.1.1 Emotional Brain BV Company Details
13.1.2 Emotional Brain BV Business Overview
13.1.3 Emotional Brain BV Female Hypoactive Sexual Desire Disorder Therapeutics Introduction
13.1.4 Emotional Brain BV Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2015-2020))
13.1.5 Emotional Brain BV Recent Development
13.2 GlaxoSmithKline Plc
13.2.1 GlaxoSmithKline Plc Company Details
13.2.2 GlaxoSmithKline Plc Business Overview
13.2.3 GlaxoSmithKline Plc Female Hypoactive Sexual Desire Disorder Therapeutics Introduction
13.2.4 GlaxoSmithKline Plc Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2015-2020)
13.2.5 GlaxoSmithKline Plc Recent Development
13.3 Palatin Technologies Inc
13.3.1 Palatin Technologies Inc Company Details
13.3.2 Palatin Technologies Inc Business Overview
13.3.3 Palatin Technologies Inc Female Hypoactive Sexual Desire Disorder Therapeutics Introduction
13.3.4 Palatin Technologies Inc Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2015-2020)
13.3.5 Palatin Technologies Inc Recent Development
13.4 Pivot Pharmaceuticals Inc
13.4.1 Pivot Pharmaceuticals Inc Company Details
13.4.2 Pivot Pharmaceuticals Inc Business Overview
13.4.3 Pivot Pharmaceuticals Inc Female Hypoactive Sexual Desire Disorder Therapeutics Introduction
13.4.4 Pivot Pharmaceuticals Inc Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2015-2020)
13.4.5 Pivot Pharmaceuticals Inc Recent Development
13.5 Strategic Science & Technologies LLC
13.5.1 Strategic Science & Technologies LLC Company Details
13.5.2 Strategic Science & Technologies LLC Business Overview
13.5.3 Strategic Science & Technologies LLC Female Hypoactive Sexual Desire Disorder Therapeutics Introduction
13.5.4 Strategic Science & Technologies LLC Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2015-2020)
13.5.5 Strategic Science & Technologies LLC Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Female Hypoactive Sexual Desire Disorder Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Female Hypoactive Sexual Desire Disorder Therapeutics Revenue
Table 3. Ranking of Global Top Female Hypoactive Sexual Desire Disorder Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of BP-101
Table 6. Key Players of Bremelanotide
Table 7. Key Players of Gepirone Hydrochloride ER
Table 8. Key Players of PVT-011
Table 9. Key Players of Others
Table 10. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Regions (2015-2020)
Table 14. Global Female Hypoactive Sexual Desire Disorder Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Female Hypoactive Sexual Desire Disorder Therapeutics Market Growth Strategy
Table 20. Main Points Interviewed from Key Female Hypoactive Sexual Desire Disorder Therapeutics Players
Table 21. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 22. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Players (2015-2020)
Table 23. Global Top Female Hypoactive Sexual Desire Disorder Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics as of 2019)
Table 24. Global Female Hypoactive Sexual Desire Disorder Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Female Hypoactive Sexual Desire Disorder Therapeutics Product Solution and Service
Table 27. Date of Enter into Female Hypoactive Sexual Desire Disorder Therapeutics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 30. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Share by Type (2015-2020)
Table 31. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Type (2021-2026)
Table 32. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Share by Application (2015-2020)
Table 33. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 34. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Share by Application (2021-2026)
Table 35. North America Key Players Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Female Hypoactive Sexual Desire Disorder Therapeutics Market Share (2019-2020)
Table 37. North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 38. North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Type (2015-2020)
Table 39. North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 40. North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Application (2015-2020)
Table 41. Europe Key Players Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Female Hypoactive Sexual Desire Disorder Therapeutics Market Share (2019-2020)
Table 43. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Type (2015-2020)
Table 45. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Application (2015-2020)
Table 47. China Key Players Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (2019-2020) (Million US$)
Table 48. China Key Players Female Hypoactive Sexual Desire Disorder Therapeutics Market Share (2019-2020)
Table 49. China Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 50. China Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Type (2015-2020)
Table 51. China Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 52. China Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Application (2015-2020)
Table 53. Japan Key Players Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Female Hypoactive Sexual Desire Disorder Therapeutics Market Share (2019-2020)
Table 55. Japan Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Type (2015-2020)
Table 57. Japan Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Female Hypoactive Sexual Desire Disorder Therapeutics Market Share (2019-2020)
Table 61. Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Type (2015-2020)
Table 63. Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Application (2015-2020)
Table 65. India Key Players Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (2019-2020) (Million US$)
Table 66. India Key Players Female Hypoactive Sexual Desire Disorder Therapeutics Market Share (2019-2020)
Table 67. India Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 68. India Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Type (2015-2020)
Table 69. India Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 70. India Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Female Hypoactive Sexual Desire Disorder Therapeutics Market Share (2019-2020)
Table 73. Central & South America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Type (2015-2020)
Table 75. Central & South America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Application (2015-2020)
Table 77. Emotional Brain BV Company Details
Table 78. Emotional Brain BV Business Overview
Table 79. Emotional Brain BV Product
Table 80. Emotional Brain BV Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2015-2020) (Million US$)
Table 81. Emotional Brain BV Recent Development
Table 82. GlaxoSmithKline Plc Company Details
Table 83. GlaxoSmithKline Plc Business Overview
Table 84. GlaxoSmithKline Plc Product
Table 85. GlaxoSmithKline Plc Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2015-2020) (Million US$)
Table 86. GlaxoSmithKline Plc Recent Development
Table 87. Palatin Technologies Inc Company Details
Table 88. Palatin Technologies Inc Business Overview
Table 89. Palatin Technologies Inc Product
Table 90. Palatin Technologies Inc Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2015-2020) (Million US$)
Table 91. Palatin Technologies Inc Recent Development
Table 92. Pivot Pharmaceuticals Inc Company Details
Table 93. Pivot Pharmaceuticals Inc Business Overview
Table 94. Pivot Pharmaceuticals Inc Product
Table 95. Pivot Pharmaceuticals Inc Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2015-2020) (Million US$)
Table 96. Pivot Pharmaceuticals Inc Recent Development
Table 97. Strategic Science & Technologies LLC Company Details
Table 98. Strategic Science & Technologies LLC Business Overview
Table 99. Strategic Science & Technologies LLC Product
Table 100. Strategic Science & Technologies LLC Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics Business (2015-2020) (Million US$)
Table 101. Strategic Science & Technologies LLC Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. BP-101 Features
Figure 3. Bremelanotide Features
Figure 4. Gepirone Hydrochloride ER Features
Figure 5. PVT-011 Features
Figure 6. Others Features
Figure 7. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Application: 2020 VS 2026
Figure 8. Out-Patient Case Studies
Figure 9. In-Patient Case Studies
Figure 10. Female Hypoactive Sexual Desire Disorder Therapeutics Report Years Considered
Figure 11. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Players in 2019
Figure 16. Global Top Female Hypoactive Sexual Desire Disorder Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Female Hypoactive Sexual Desire Disorder Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Female Hypoactive Sexual Desire Disorder Therapeutics Revenue in 2019
Figure 18. North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
心的外傷後ストレス障害（PTSD）治療薬の世界市場（～2026年） Post-Traumatic Stress Disorder (PTSD) therapeutics include drugs that are used in the treatment of PTSD. The rising prevalence of PTSD to be one of the primary growth factors for the post-traumatic stress disorder (PTSD) therapeutics market. Market Analysis and Insights: Global Post-Traumatic Stress…- 睡眠障害治療薬の世界市場（～2026年） Sleep disorders result in a lack of deep and restorative sleep. The sleep disorder therapeutics market is expected to witness a high growth over the forecast period owing to the increasing prevalence of sleep disorder in modern times. Market Analysis and Insights: Global Sleep Disorder Therapeutics …
- 注意欠陥・多動性障害（ADHD）治療薬の世界市場（～2026年） ADHD is a brain/neurodevelopmental/neurobehavioral disorder characterized by pervasive and impairing symptoms of inattention, hyperactivity, and impulsivity. The Centers for Disease Control and Prevention (CDC) defines “neurobehavioral” as the way the brain affects emotion, behavior, and learning. G…
- 性的ウェルネス製品の世界市場（～2026年） Sexual wellness refers to the physical, mental, and sexual well-being of people. Products such as erotic lingerie, condoms and contraceptives, personal lubricants, sex toys, and others such as testing cards and pregnancy testing kits, sexual enhancement supplements, sex games, and vaginal sexual wel…
- 双極性障害治療薬の世界市場（～2026年） Bipolar disorder, also known as manic depression, is a mental disorder that could lead to periods of depression and elevated mood. The treatment of bipolar disorder includes psychotherapy as well as medications such as mood stabilizers and antipsychotics. Rise in prevalence of bipolar disorder, high…